The professional association for
Federal Equity Receivers
The National Association of Federal Equity Receivers (NAFER) is made up of leading professionals who work in the area of receivership, insolvency, bankruptcy, restructuring, and international asset recovery.
Join Today!
Become a part of the network of esteemed professionals in the only association dedicated to the receivership practice. Start receiving your membership benefits today!
The Receiver is the official publication for all NAFER members. Our Publications Committee keeps our members up to date on recent case rulings and legal briefs, agency and member news, professional papers and other general updates. If it’s important to the receivership and restructuring community, you’ll find it in The Receiver.
Protecting “Evil Zombie Standing” in Federal Court: How NAFER is Helping Receivers to Recover from Wrongdoers
By David A. Castleman & Varinder P. Singh
No legal issue is more important to federal equity receivers than their ability to recover money on behalf of injured consumers or investors.
Thank You to Our Partners
Our sponsors are the backbone of our organization. Because of the continued generous support of these business partners, we have the ability to continually provide quality education in top rated locations around the country. It is because of the commitment from these sponsors that we are able to host highly anticipated annual conferences each year. When selecting services and partners for your business needs, be sure to look to our partners first!
Photo Gallery
NAFER 2023 Annual Conference in Nashville, TN
Industry News
The latest news from the industry
- SEC Investor Advisory Committee to Examine Mandatory Arbitration Clauses in Adviser Agreements and Alternative Assets and Retail Investors at December 10 Meetingon December 3, 2024
The Securities and Exchange Commission’s Investor Advisory Committee will hold a virtual public meeting on Dec. 10, 2024, at 10 a.m. ET. The meeting will be webcast on the SEC website. The committee will host two panels: Examining the Use of…
- SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviewson December 3, 2024
The Securities and Exchange Commission today filed settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio Chiriva-Internati, and its former chief financial officer, Tony Tontat, for failing to…
- SEC Updates List of Firms Using Inaccurate Information to Solicit Investorson November 27, 2024
The Securities and Exchange Commission today announced that it updated its list of unregistered entities that use misleading information to solicit primarily non-U.S. investors, adding 14 soliciting entities, two impersonators of genuine firms, and four…